Vernalis
Cambridge, United Kingdom vernalis.com
From their website, Nov 2026
Work here? Claim this listing
About
Vernalis is a drug discovery CRO that works with biotech, pharma and other collaborators on early discovery programs from hit identification to candidate selection. It provides integrated services in protein sciences, screening, structural biology, chemistry, biophysics, cell biology, ADME/DMPK, informatics and in vivo pharmacology from its site in Cambridge, United Kingdom.
Services
Protein Sciences
Produces and characterises proteins for drug discovery, including construct design, expression and purification across multiple systems.
Protein production
Hit Identification Services
Finds starting points for targets using biochemical assays, DEL, ASMS, in silico screening and fragment-based drug discovery.
Assays & in vitro testing
Hit ID Platform
Provides end-to-end hit identification across multiple screening platforms.
Assays & in vitro testing
Chemistry / Hit to Lead Services
Designs, synthesises and optimises compounds from fragment hits to lead series and beyond.
Structural Biology Services
Determines protein and ligand-protein structures using X-ray crystallography and NMR to guide drug design.
Assays & in vitro testing
Biophysical Screening Services
Validates and characterises hits using NMR, SPR, ITC, MST, TSA and ASMS.
Assays & in vitro testing
Drug Discovery Informatics
Applies cheminformatics, data science and software engineering to support data-driven discovery decisions.
Cell Biology Services
Runs cell-based assays to assess target engagement, compound activity and mechanism of action.
Assays & in vitro testing
ADME DMPK Services
Provides in vitro ADME profiling, metabolite identification and ex vivo bioanalysis to support candidate selection.
ADME, DMPK & toxicology
In Vivo Pharmacology Services
Supports outsourced in vivo study design, management, bioanalysis and PK/PD analysis through external CRO partners.
ADME, DMPK & toxicology
DEL Technology
Screens DNA-encoded libraries against protein targets to identify hits for challenging targets.
Assays & in vitro testing
PAC-FragmentDEL
Uses photoactivated covalent capture with DNA-encoding for fragment screening with small protein requirements.
Assays & in vitro testing
Fragment-Based Drug Discovery
Screens low-molecular-weight fragments and grows them into lead series using integrated screening, structural and chemistry expertise.
Assays & in vitro testing
Protein Science
Expresses, purifies, and engineers proteins for biophysical and structural studies.
Protein production
Hit ID and Assay
Finds and validates hits using biochemical assays, DEL, in silico screening, fragment-based drug discovery, and assay development.
Assays & in vitro testing
Biophysics and Structural Biology
Uses NMR, mass spectrometry, SPR, ITC, and X-ray crystallography to validate and progress chemical series.
Assays & in vitro testing
Chemistry and Computational
Supports medicinal chemistry, synthetic chemistry, flow chemistry, analytical chemistry, and computational chemistry for lead optimization and candidate selection.
Cell biology
Characterizes and supports chemical series through cell biology studies.
Assays & in vitro testing
DMPK
Supports chemical series through lead optimization and pre-clinical studies with DMPK work.
ADME, DMPK & toxicology
- What to send
- Minimal protein requirement for PAC-FragmentDEL · Small amounts of target protein for PAC-FragmentDEL
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule · Peptide · NMR · SPR · Biochemical assays · Mammalian expression · Insect cells
- Capacity
- Screening billions of compounds in one experiment · Over 8,000 crystal structures determined for more than 70 targets · Multiple expression systems: E. coli, yeast, insect and mammalian cell · Milligram-to-kilogram capabilities · Bioreactor for precise control of growth conditions and optimal yield · 50k lead-like chemical space screening library
- Data supplied
- NMR
Equipment
- Biacore T200
- Biacore 1S+
- Biacore 8K
- Bruker D8 venture
- LC-MS/MS
- LCMS-MS
- NMR
- SPR
- ITC
- MST
- TSA
- ASMS
- X-ray crystallography
- Next Generation Sequencing
- ÄKTA Pure
- ÄKTA Avant
- Agilent QTOF
- Syrris Asia flow chemistry systems
Materials
- Yeast
- Insect cells
Industries served
- Biotech
- Pharma
Company
- Type
- CRO
- Founded
- 2001
- Size
- 51-200 employees
Locations
- Address
- 01 Find Us Granta Park is just 8 miles from Cambridge city centre, 20 minutes from London St
- Sites
- Cambridge, United Kingdom
Public records
- Wikidata
- Q7921942 source
Similar labs
Work here? Claim this listing